Pancreatic cancer has a significantly poor prognosis; therefore, the development of effective treatments is an unmet clinical need. The major drawback in this field was the lack of useful model ...
Some genetic disorders—such as cystic fibrosis, hemophilia and Tay Sachs disease—involve many mutations in a person's genome, ...
This story is part of a series on the current progression in Regenerative Medicine. In 1999, I defined regenerative medicine as the collection of interventions that restore tissues and organs damaged ...
An early-stage company is using machine learning to design bespoke nonviral delivery methods for future gene therapies. Nanite, set up two years ago, plans to use machine learning to design polymers ...
In utero delivery of Cas9 mRNA/gRNA with ADP-LNPs results in widespread editing of cells in the fetal brain. Credit: UC Davis In utero delivery of Cas9 mRNA/gRNA with ADP-LNPs results in widespread ...
Vector BioPharma AG (Vector BioPharma), a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery to improve treatments for patients, today announced that ...
Genetic engineering in non-human primates has long been limited by the need for virus-based gene delivery methods. Recently, researchers in Japan successfully used a nonviral system to introduce a ...
However, traditional gene delivery methods, such as Agrobacterium-mediated transformation and gene guns, are often slow, inefficient, and can damage plant tissues. These highlight the need for more ...
Niigata, Japan – The research group of Professor Kamimura in Niigata University have established a novel pancreatic carcinogenesis model in wild-type rats utilizing the pancreas-targeted selective ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback